DONATE

IBEC book artist shortlisted for illustration prize

Artist Miguel Bustos was a finalist in a prestigious illustration prize for his work last year on IBEC’s Anniversary Book, ’10 anys d’impacte’.

The 16th edition of the Premis Junceda of the Associació Professional d’il·lustradors de Catalunya saw Miguel up against four other finalists for a prize in the ‘non-fiction book for adults or children’ section. The jury of illustrators is made up of winners of previous calls and personalities from the world of visual communication.

Two projects for IBEC at AECC ceremony

On Monday IBEC junior group leader Nuria Montserrat and senior researcher Aranzazu Villasante were two of the researchers awarded funding at the Asociación Española de Investigación sobre el Cáncer (AECC)’s ceremony in Madrid.

The AECC has bestowed 160 grants on cancer researchers during the past year, a total of €17.6m. The association made the official presentations of these awards at an event presided over by Her Majesty Queen Letizia on World Cancer Research Day, 24th September 2018.

UB master programme wins EIT Label

A University of Barcelona master programme in which IBEC participates has been awarded the EIT Label, a certificate of quality for master and doctoral programmes, from EIT Health.

The Master of Technological Innovation in Health (MTIH), led by Sorbonne University, has achieved the EIT Label for its excellent scientific education coupled with innovation and entrepreneurship training. IBEC’s role in the degree programme includes the active participation of students, as well as the innovative technology for health being developed by IBEC’s researchers, many of whom teach on the programme.

Implemented by a consortium of five universities in France, Spain and Portugal, the MTIH provides ‘active learning’ methods and supports student mobility, and new teaching content is being added to strengthen students’ innovation and entrepreneurship expertise.

The way tumor cells expand challenges current physics

Researchers from IBEC and UB have discovered that the way tumor cells expand defies the laws of physics.

In an article published today in Nature Physics, the researchers have challenged our current understanding of the discipline and developed a new framework that could help predict the conditions under which tumors initiate metastasis.

IBEC and TU/e plant the seed of a promising partnership

Eight IBECers were in the Netherlands on 13th and 14th September for the first ever IBEC-ICMS Symposium, ‘NanoSens&Med’.

The event aimed to identify synergies and potential for collaboration between IBEC groups and the researchers of the Institute for Complex Molecular Systems (ICMS), a research institute of the Eindhoven University of Technology (TU/e).

Two IBEC group leaders, Vito Conte and Lorenzo Albertazzi, already have dual appointments with ICMS. They opened the symposium by welcoming all participants from the two institutions and presented their research, as did Eduard Torrents, Elena Martinez, Silvia Muro, Nuria Montserrat, Samuel Sanchez and director Josep Samitier, who also introduced IBEC.

Laboratory Technician (mouse embryologist technician) – (Ref. TC-SO)

Application Deadline: 05/10/2018
Ref: TC-JR

The Open Lab in Bioengineering in Reproductive Health, led by Dr. Samuel Ojosnegros at the Institute for Bioengineering of Catalonia (IBEC) ) is looking for a Mouse embryologist technician to participate in a study of imaging the early mammalian development.

New IBEC group creates ‘fitness heatmaps’ of gene mutations

The start of the autumn semester finds a new face in IBEC’s research community, with Dr. Benedetta Bolognesi joining the institute as junior group leader.

Benedetta has come from Barcelona’s Centre for Genomic Regulation, where she was a postdoc in Ben Lehner’s and Gian Gaetano Tartaglia’s groups. At IBEC she will launch and lead the Protein Phase Transitions in Health and Disease group.

During her postdoc, Benedetta focused on why certain genes are toxic when over-expressed. She found that, in some cases, they cause toxicity because the proteins they code for end up forming a different liquid phase in the cytoplasm.